. . . . . . . . . . . "a(CHEBI:resveratrol) -> r(HGNC:FASLG)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "We also show that resveratrol treatment enhances CD95L expression on HL60 cells, as well as T47D breast carcinoma cells, and that resveratrol-mediated cell death is specifically CD95-signaling dependent." . . "Selventa" . . . . "2014-07-03T14:34:11.513+02:00"^^ . . .